miércoles, 3 de julio de 2019

A biotech scorecard for the third quarter: 12 stock-moving events to watch

A biotech scorecard for the third quarter: 12 stock-moving events to watch

Daily Recap

STAT Plus: The biotech scorecard for the third quarter: 12 stock-moving events to watch

By ADAM FEUERSTEIN


RYAN PIERSE/GETTY IMAGES
Amarin’s stock price could move most on an event that doesn’t happen and Sangamo Therapeutics is presenting updated clinical data on its gene therapy.

No hay comentarios: